Antineoplaston Therapy in Treating Patients With Colon Cancer

Withdrawn before enrolling · Phase 2

Conditions studied: Stage IV Colon Cancer, Recurrent Colon Cancer, Adenocarcinoma of the Colon

In brief

RATIONALE: Antineoplastons are naturally occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial is studying how well antineoplaston therapy works in treating patients with colon cancer.

Key facts

Study ID

NCT00003486

Run by

Burzynski Research Institute

People needed

0

Last updated by the study team

2013-07-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Burzynski Clinic — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.